Australian Pharmaceutical Industries Ltd
ASX:API
Australian Pharmaceutical Industries Ltd
Cash from Investing Activities
Australian Pharmaceutical Industries Ltd
Cash from Investing Activities Peer Comparison
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Australian Pharmaceutical Industries Ltd
ASX:API
|
Cash from Investing Activities
-AU$68.9m
|
CAGR 3-Years
6%
|
CAGR 5-Years
-39%
|
CAGR 10-Years
N/A
|
|
Paragon Care Ltd
ASX:PGC
|
Cash from Investing Activities
-AU$40.3m
|
CAGR 3-Years
-22%
|
CAGR 5-Years
21%
|
CAGR 10-Years
-95%
|
|
Sigma Healthcare Ltd
ASX:SIG
|
Cash from Investing Activities
AU$5.7m
|
CAGR 3-Years
-64%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Cronos Australia Ltd
ASX:CAU
|
Cash from Investing Activities
-AU$837.7k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Australian Pharmaceutical Industries Ltd's Cash from Investing Activities?
Cash from Investing Activities
-68.9m
AUD
Based on the financial report for Aug 31, 2021, Australian Pharmaceutical Industries Ltd's Cash from Investing Activities amounts to -68.9m AUD.
What is Australian Pharmaceutical Industries Ltd's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 5Y
-39%
The average annual Cash from Investing Activities growth rates for Australian Pharmaceutical Industries Ltd have been 6% over the past three years , -39% over the past five years .